What Researchers Did
This review examined the potential of hyperbaric oxygen therapy (HBOT) to prevent or mitigate neurological side effects caused by cranial irradiation.
What They Found
While radiosurgery has a high success rate of approximately 95%, about 5% of patients experience neurological problems due to irradiation-induced inflammation. Existing studies suggest that hyperbaric oxygen therapy (HBOT) administered after the onset of these neurological side effects can reduce their incidence and severity.
What This Means for Canadian Patients
For Canadian patients undergoing cranial irradiation, hyperbaric oxygen therapy (HBOT) may offer a potential strategy to reduce the severity and occurrence of neurological side effects. This could lead to improved quality of life and better neurological outcomes for those affected by radiation-induced damage.
Canadian Relevance
This review article does not have a direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature and highlights that the exact mechanisms of irradiation-induced damage and HBOT's effects are still not fully understood.